This was established by correlating the reduction in TIMP levels with increased cancer cell invasiveness, while supplementation with TIMP-1 (2.1 nM) and TIMP-2 (2.5 nM) significantly inhibited the chemerin-induced migration and invasion responses. The gene discussed is TIMP2; the disease is cancer.